Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Healthtrust
Federal Trade Commission
Moodys
Fish and Richardson
Cipla
Argus Health
Covington
Express Scripts

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019983

« Back to Dashboard

NDA 019983 describes PROSTEP, which is a drug marketed by Aveva and is included in one NDA. Additional details are available on the PROSTEP profile page.

The generic ingredient in PROSTEP is nicotine. There are thirty drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the nicotine profile page.
Summary for 019983
Tradename:PROSTEP
Applicant:Aveva
Ingredient:nicotine
Patents:0
Therapeutic Class:Antidotes, Deterrents, and Toxicologic Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 019983

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength11MG/24HR
Approval Date:Dec 23, 1998TE:RLD:No

Profile for product number 004

Active Rx/OTC/Discontinued:DISCNDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength22MG/24HR
Approval Date:Dec 23, 1998TE:RLD:No

Expired US Patents for NDA 019983

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aveva PROSTEP nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 019983-003 Dec 23, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Aveva PROSTEP nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 019983-004 Dec 23, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Fish and Richardson
Federal Trade Commission
Cerilliant
Julphar
Express Scripts
Medtronic
QuintilesIMS
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.